Community pharmacy and cash reward: A winning combination for chlamydia screening?

Sexually Transmitted Infections

Volumn 89, Issue 3, 2013, Pages 212-216

  Currie, Marian J ^a   Deeks, Louise S ^a,b   Cooper, Gabrielle M ^b   Martin, Sarah J ^a,c   Parker, Rhian M ^d   Del Rosario, Rendry ^c   Hocking, Jane S ^e   Bowden, Francis J ^a,c  

^a The Australian National University   (Australia)

^b UNIVERSITY OF CANBERRA   (Australia)

^c CANBERRA HOSPITAL   (Australia)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASH REWARD; CHLAMYDIASIS; COMMUNITY PHARMACY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE COST; HEALTH EDUCATION; HUMAN; MALE; PELVIC INFLAMMATORY DISEASE; PHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; REWARD; SCREENING TEST; URINALYSIS;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; FEMALE; HUMANS; MALE; MASS SCREENING; PHARMACIES; QUESTIONNAIRES; REWARD; URINE; YOUNG ADULT;

EID: 84878209610     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050357     Document Type: Article

References (28)

1. Department of Health and Ageing (Australian Government). National Notifiable Disease Surveillance System. http://www9.health.gov.au/cda/Source/ Rpt-3.cfm (accessed 6 Sep 2011).
2. Health Protection Agency. STI Table 6: Chlamydia. http://www.hpa.org.uk/ stiannualdatatables#2.-Trends-in-STI-diagnoses (accessed 8 Sep 2011).
3. Centres for Disease Control and Prevention (CDC). STD Surveillance, 2009 - National Overview. http://www.cdc.gov/std/stats09/natoverview.htm (accessed 6 Sep 2011).
4. Kong FY, Guy RJ, Hocking JS, et al. Australian general practitioner chlamydia testing rates among young people. Med J Aust 2011;194:249-52.
5. Currie MJ, Schmidt M, Davis BK, et al. 'Show me the money': financial incentives increase chlamydia screening rates among tertiary students: a pilot study. Sex Health 2010;7:60-5.
6. Morris SR, Bauer HM, Chartier M, et al. Relative efficiency of chlamydia screening in non-clinical settings in two California counties. Int J STD AIDS 2010;21:52-6.
7. Bowden FJ, O'Keefe EJ, Primrose R, et al. Sexually transmitted infections, blood-borne viruses and risk behaviour in an Australian senior high school population-the SHLiRP study. Sex Health 2005;2:229-36.
8. TNS Healthcare. Pharmacy Chlamydia Screening Pathfinder Evaluation (PCSPf) Final: Wave Three. Copyright 2007 Taylor Nelson Sofres plc. London: Department of Health, 2007.
9. van Bergen JE, Postma MJ, Peerbooms PG, et al. Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples. Int J STD AIDS 2004;15:797-802. (Pubitemid 40018703)
10. Emmerton L, Buhrer Skinner M, Gardiner E, et al. A trial of the distribution of chlamydia self-collection postal specimen kits from Australian community pharmacies. Sex Health 2010;8:130-2.
11. Gudka S, Marshall L, Creagh A, et al. To develop and pilot a best practice community pharmacy chlamydia screening model. Pharmacy Guild of Australia Research and Development Program Perth Western Australia University of Western Australia (Pharmacy Department), Freemantle Hospital, Family Planning Western Australia, 2010.
12. Brabin L, Thomas G, Hopkins M, et al. Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study. BMC Women's Health 2009;9:7.
13. National Chlamydia Screening Programme (NCSP), 2011. http://www. chlamydiascreeingnhs.ik/ps/assets/pdfs/data/shapresentations11/ Q1-4%202010-11%ENGLAND.pdf.london2012 (accessed 16 Jan 2012).
14. Volpp KG, Troxel AB, Pauly MV, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009;360:699-709.
15. Thornley LM, Marsh K. What Works in Social Marketing to Young People? Systematic Review for the Health Research Council of New Zealand and the Ministry of Youth Development Final Report, 2010. www.myd.govt.nz/documents/ policy.../social-marketing-syst-rev-final.pdf (accessed 23 Jan 2012).
16. National Pharmaceutical Association. NPA Survey, 2010. http://www.npa.co.uk/representing-you/campaigns/pharmacy-facts/ (accessed 23 Jan 2012).
17. Buhrer Skinner M. Trial of a self-collection kit for chlamydia testing in various settings in Queensland: The Chlamydia Testing Trial. Anton Breinl Centre for Public Health and Tropical Medicine: James Cook University, 2009:41-6.
18. Gudka S, Marshall L, Creagh A, et al. To develop and pilot a best practice community pharmacy chlamydia screening model. Pharmacy Guild of Australia Research and Development Program Perth Western Australia University of Western Australia (Pharmacy Department), Freemantle Hospital, Family Planning Western Australia, 2010.
19. Baraitser P, Pearce V, Holmes J, et al. Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London. Qual Saf Health Care 2007;16:303-7. (Pubitemid 47262403)
20. Chen MY, Donovan B. Screening for genital Chlamydia trachomatis infection: Are men the forgotten reservoir? Medical Journal of Australia 2003;179:124-5. (Pubitemid 37025185)
21. Australian Government. Horizon Scanning Technology Prioritising Summary: Opportunistic screening of asymptomatic individuals for chlamydia. Adelaide Department of Health and Ageing, 2007. http://www.horizonscanning.gov.au (accessed 1 Jul 2012).
22. Australian Bureau of Statistics. 31010DO001-200912 Australian Demographic Statistics, Dec 2009. http://www.abs.gov.au/ (accessed 12 Aug 2010)
23. Medicare Australia. Chlamydia testing data - MBS-Data-1605609182.4.xls; MBS-Data-1605609271.9.xls. http://www.medicareaustralia.gov.au/ (accessed 12 Aug 2010).
24. Vajdic CM, Middleton M, Bowden FJ, et al. The prevalence of genital Chlamydia trachomatis in Australia 1997-2004: a systematic review. Sex Health 2005;2:169-83.
25. Anderson C, Thornley T. A pharmacy-based private chlamydia screening programme: results from the first 2 years of screening and treatment. Int J Clin Pharm 2011;33:88-91.
26. Marteau TM, Ashcroft RE, Oliver A. Using financial incentives to achieve healthy behaviour. BMJ 2009;338:b1415.
27. Lawton BA, Rose SB, Elley CR, et al. Increasing the uptake of opportunistic chlamydia screening: a pilot study in general practice. J Primary Health Care 2010;2:199-207.
28. Bilardi JE, Fairley CK, Temple-Smith MJ, et al. Incentive payments to general practitioners aimed at increasing opportunistic testing of young women for chlamydia: a pilot cluster randomised controlled trial. BMC Public Health 2010;10:70.